Related references
Note: Only part of the references are listed.Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls
Justin M. Zook et al.
NATURE BIOTECHNOLOGY (2014)
mrsFAST-Ultra: a compact, SNP-aware mapper for high performance sequencing applications
Faraz Hach et al.
NUCLEIC ACIDS RESEARCH (2014)
Establishment of CYP2D6 reference samples by multiple validated genotyping platforms
H. Fang et al.
PHARMACOGENOMICS JOURNAL (2014)
An integrated map of genetic variation from 1,092 human genomes
David M. Altshuler et al.
NATURE (2012)
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Qiang Ma et al.
PHARMACOLOGICAL REVIEWS (2011)
Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1 A GeT-RM and Association for Molecular Pathology Collaborative Project
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
mrsFAST: a cache-oblivious algorithm for short-read mapping
Faraz Hach et al.
NATURE METHODS (2010)
Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants
Andrea Gaedigk et al.
FRONTIERS IN PHARMACOLOGY (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part II
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Personalized copy number and segmental duplication maps using next-generation sequencing
Can Alkan et al.
NATURE GENETICS (2009)
CYP2D6: novel genomic structures and alleles
Whitney E. Kramer et al.
PHARMACOGENETICS AND GENOMICS (2009)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
Share Paper
